Reasons for Failure and Relapse and Mechanism...

Stay up to date with the latest EHA guidelines on Hodgkin lymphoma. In this episode of EHA Unplugged, key guideline authors Prof. Dennis Eichenauer and Prof. Igor Aurer discuss the evidence reshaping the management of classic Hodgkin lymphoma. The discussion highlights the guidel ...  Show more

In this episode, Prof Gianluca Gaidano, recipient of the EHA2026 Diversity, Equity and Inclusion Award, explores how promoting equity, inclusion, and access to care has shaped his work within EHA and beyond. He reflects on educational initiatives in underrepresented regions, incl ...  Show more

In Part 1 of this pair of episodes, Drs. Rita Dib and Joseph Sassine provide a background of CAR-T cell therapy (chimeric antigen receptor T cells) and steer you through the complications that might contribute to fever early after CAR-T.Episodes | Consult Notes | Subscribe | Twit ...  Show more

In Part 2 of this pair of episodes, Drs. Rita Dib and Joseph Sassine zoom through the late infectious complications of CAR-T cell therapy.Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com 

This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ...

How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024.
  
Credit available for this activity expires: 07/31/25
Earn Credit / Learning Obje ...